Tang Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tang Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-490,000	Closed	-$6.32M	–	9
2014 Q4	$6.32M	Buy	490,000 +190,000	+63%	+$2.38M	3.46%	7
2014 Q3	$3.68M	Sell	300,000 -700,000	-70%	-$8.13M	1.91%	9
2014 Q2	$15.8M	Hold	1,000,000	–	–	7.33%	5
2014 Q1	$15.1M	Buy	+1,000,000	New	+$11.3M	7.33%	5

Other funds holding HZNP

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Tang Capital Management's HZNP Position: Q1 2015 in Review

Tang Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2015, closing a stake of 490,000 shares — an estimated $6.32M sold.

Tang Capital Management first reported a position in HZNP in Q1 2014 and held it in 4 quarters. The position peaked at $15.8M in Q2 2014. 177 funds tracked by Wall St. Rank hold HZNP as of Q1 2015.

Tang Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2015 after selling out during the quarter.
Tang Capital Management sold 490,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2015, an estimated $6.32M.
Tang Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 4 quarters.
Tang Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.8M in Q2 2014.
177 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2015.

Based on Tang Capital Management's 13F filing for Q1 2015, filed 15 May 2015.